BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8097671)

  • 1. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport.
    Chen HX; Bamberger U; Heckel A; Guo X; Cheng YC
    Cancer Res; 1993 May; 53(9):1974-7. PubMed ID: 8097671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells.
    Tatsuta T; Shimizu K; Nishimura T; Suzuki H
    Anticancer Drug Des; 1991 Jul; 6(3):179-88. PubMed ID: 1678605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
    Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
    Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding.
    Curtin NJ; Bowman KJ; Turner RN; Huang B; Loughlin PJ; Calvert AH; Golding BT; Griffin RJ; Newell DR
    Br J Cancer; 1999 Aug; 80(11):1738-46. PubMed ID: 10468290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.
    Shalinsky DR; Andreeff M; Howell SB
    Cancer Res; 1990 Dec; 50(23):7537-43. PubMed ID: 1979245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
    Wang Y; Georges E
    Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical modulation of 'classical' multidrug resistance by BIBW22BS, a potent derivative of dipyridamole.
    Jansen WJ; Pinedo HM; Kuiper CM; Lincke C; Bamberger U; Heckel A; Boven E
    Ann Oncol; 1994 Oct; 5(8):733-9. PubMed ID: 7826906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.
    Foxwell BM; Mackie A; Ling V; Ryffel B
    Mol Pharmacol; 1989 Oct; 36(4):543-6. PubMed ID: 2572960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R
    Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines.
    Asoh K; Saburi Y; Sato S; Nogae I; Kohno K; Kuwano M
    Jpn J Cancer Res; 1989 May; 80(5):475-81. PubMed ID: 2568984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A fungus-derived novel nucleoside transport inhibitor potentiates the activity of antitumor drugs].
    Su J; Zhen YS; Qi CQ; Chen WJ
    Yao Xue Xue Bao; 1994; 29(9):656-61. PubMed ID: 7900536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS; Thimmaiah P; Thimmaiah KN
    Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; BĂ©liveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
    Dantzig AH; Shepard RL; Cao J; Law KL; Ehlhardt WJ; Baughman TM; Bumol TF; Starling JJ
    Cancer Res; 1996 Sep; 56(18):4171-9. PubMed ID: 8797588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole enhancement of etoposide sensitivity.
    Howell SB; Hom DK; Sanga R; Vick JS; Chan TC
    Cancer Res; 1989 Aug; 49(15):4147-53. PubMed ID: 2545335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
    Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K
    Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
    Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.